The doctor listed fatigue-like early signs of a heart attack.
In 2025, the hospital mortality rate from a heart attack in Russia was 9.5%. Cardiologist Irina Tarasova told Mail Health on Wednesday, November 11, what symptoms can warn of an impending heart attack.
According to the specialist, the first signs sometimes appear a few days or even weeks before a heart attack. One of the most characteristic symptoms is heaviness, pressure, or burning behind the sternum that occurs during physical exertion and passes at rest. Pain can also radiate to the arm, shoulder, back, neck, lower jaw, or upper abdomen.
Other alarming signals may include shortness of breath during habitual exertion, unexplained severe fatigue, and a sudden feeling of anxiety or fear. Tarasova also recommended paying attention to sleep disorders, especially if a person has to put an extra pillow to make breathing easier.
The cardiologist stressed that a developing heart attack can be accompanied by intense pressing or burning pain behind the sternum lasting more than 20 minutes, marked shortness of breath, cold sweat and a sharp pallor of the skin. If such symptoms occur, an ambulance should be called immediately. If a heart attack is suspected, do not wait until the pain lasts 20 minutes.
Cardiologist Olga Savonina said on November 11 that a heart attack can happen even to a young person, although the average age of patients in Russia is approaching 64 years, writes RT. Among the main risk factors for heart attack, Savonina identified smoking, high blood pressure, diabetes, high cholesterol and heredity. She recommended not postponing a visit to the doctor until the age of 60. 360.ru .
Doctor Alexander Umnov warned that among the dangerous signs of a heart attack is a pressing or burning pain in the chest, which can radiate to the left arm, jaw, back or under the shoulder blade. kp.ru .
In early November, Viktor Sirotenko, Dean of the Faculty of Pharmacy at Volgograd State Medical University, Doctor of Pharmacy, announced that the Russian drug Angipur, which is being developed for use in myocardial infarction and coronary artery surgery, may appear on the market within one to two years.
Переведено сервисом «Яндекс Переводчик»